Evidence map›Paper›PMID 31242442›Full record

ArticleNeuroscience2019

Escalated Alcohol Self-Administration and Sensitivity to Yohimbine-Induced Reinstatement in Alcohol Preferring Rats: Potential Role of Neurokinin-1 Receptors in the Amygdala.

Britta S Nelson, Hannah D Fulenwider, Sadie E Nennig, Britessia M Smith, Michelle K Sequeira, Scott H Chimberoff, Christopher T Richie, Kejun Cheng, Kenner C Rice, Brandon K Harvey and 2 more

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. HepaticeLife · 2021
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Britta S NelsonDepartment of Physiology and Pharmacology, University of Georgia, Athens, Georgia.
Hannah D FulenwiderDepartment of Physiology and Pharmacology, University of Georgia, Athens, Georgia.
Sadie E NennigDepartment of Physiology and Pharmacology, University of Georgia, Athens, Georgia.
Britessia M SmithDepartment of Physiology and Pharmacology, University of Georgia, Athens, Georgia.
Michelle K SequeiraDepartment of Physiology and Pharmacology, University of Georgia, Athens, Georgia.
Scott H ChimberoffDepartment of Physiology and Pharmacology, University of Georgia, Athens, Georgia.
Christopher T RichieOptogenetic and Transgenic Technology Core, National Institute on Drug Abuse, Baltimore, MD, USA.
Kejun ChengSection on Drug Design and Synthesis, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, Bethesda, MD, USA.
Kenner C RiceSection on Drug Design and Synthesis, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, Bethesda, MD, USA.
Brandon K HarveyOptogenetic and Transgenic Technology Core, National Institute on Drug Abuse, Baltimore, MD, USA.
Markus HeiligCenter for Social and Affective Neuroscience, Linkoping University, Linkoping, Sweden.
Jesse R SchankDepartment of Physiology and Pharmacology, University of Georgia, Athens, Georgia. Electronic address: jschank@uga.edu.
University of Georgia · USNational Institute on Alcohol Abuse and Alcoholism · USNational Institute on Drug Abuse · USLinköping University · SE

Funding

Gene Delivery and AddictionZIADA000526 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2009 to 2022
$3.2M
The Role of the Neurokinin-1 Receptor and NF kappa B in alcohol-induced behaviorR00AA021805 · NIAAA · UNIVERSITY OF GEORGIA · PI SCHANK, JESSE R · 2014 to 2016
$724k
NIAAA NIH HHS R00 AA021805
6 · The paper itself

Abstract

Genetic factors significantly contribute to the risk for developing alcoholism. To study these factors and other associated phenotypes, rodent lines have been developed using selective breeding for high alcohol preference. One of these models, the alcohol preferring (P) rat, has been used in hundreds of preclinical studies over the last few decades. However, very few studies have examined relapse-like behavior in this rat strain. In this study, we used operant self-administration and yohimbine-induced reinstatement models to examine relapse-like behavior in P rats. Our previous work has demonstrated that P rats show increased expression of the neurokinin-1 receptor (NK1R) in the central nucleus of the amygdala (CeA), and this functionally contributes to escalated alcohol consumption in this strain. We hypothesized that P rats would show increased sensitivity to yohimbine-induced reinstatement that is also mediated by NK1R in the CeA. Using Fos staining, site-specific infusion of NK1R antagonist, and viral vector overexpression, we examined the influence of NK1R on the sensitivity to yohimbine-induced reinstatement of alcohol seeking. We found that P rats displayed increased sensitivity to yohimbine-induced reinstatement as well as increased neuronal activation in the CeA after yohimbine injection compared to the control Wistar strain. Intra-CeA infusion of NK1R antagonist attenuates yohimbine-induced reinstatement in P rats. Conversely, upregulation of NK1R within the CeA of Wistar rats increases alcohol consumption and sensitivity to yohimbine-induced reinstatement. These findings suggest that NK1R upregulation in the CeA contributes to multiple alcohol-related phenotypes in the P rat, including alcohol consumption and sensitivity to relapse.

Indexed as

Adrenergic alpha-2 Receptor AntagonistsAlcohol-Related DisordersAnimalsCentral Amygdaloid NucleusCentral Nervous System DepressantsConditioning, OperantDisease Models, AnimalEthanolMaleNeurokinin-1 Receptor AntagonistsNeuronsProto-Oncogene Proteins c-fosRats, WistarReceptors, Neurokinin-1RecurrenceSelf AdministrationAdrenergic alpha-2 Receptor AntagonistsCentral Nervous System DepressantsEthanolNeurokinin-1 Receptor AntagonistsProto-Oncogene Proteins c-fosReceptors, Neurokinin-1Yohimbinecentral nucleus of amygdalaP ratrelapsesubstance P

Identifiers

PMID31242442
PMCPMC6666424
OpenAlexW2953227535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.